GLP-1 analogs, which originated for the treatment of diabetes, are proving to be extremely effective for the treatment of obesity and for regulation of molecular pathways involved in inflammation, oxidative stress, lipid metabolism, insulin activity, as well as androgen synthesis, gaining promising results in animal studies testing their efficacy on spontaneous pregnancy rates. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.